NCBiotech Targets Personalized Medicine
News | 14 June 2012
June 14, 2012 By: NCTechNews Category: Biotechnology. (Research Triangle Park, N.C.) The North Carolina Biotechnology Center has approved a $100000 ...
Click on the link to read the full article at NCTechNews (press release)
(This link will open in a new window)
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
